CSF1R相关脑白质病:原发性小胶质细胞病的主要成员
本文综述CSF1R相关脑白质病的临床、影像和病理特征:患者多在40-50岁出现额颞叶痴呆样表现,伴锥体束和锥体外系运动症状,女性发病年龄较早;脑影像可见白质异常、胼胝体变薄、白质弥散受限病灶和脑钙化;病理提示原发性轴索病继发脱髓鞘;CSF1R单倍剂量不足在小鼠模型和体外实验中得到验证,但选择性导致白质变性的机制尚待阐明。
要点
- CSF1R相关脑白质病多在40-50岁起病,呈额颞叶痴呆样表型,伴锥体束和锥体外系症状。
- 脑影像标志包括白质异常、胼胝体变薄、白质弥散受限病灶和脑钙化。
- 病理提示原发性轴索病继发脱髓鞘,CSF1R单倍剂量不足在小鼠模型和体外实验中得到验证。
核心结论
- CSF1R相关脑白质病是原发性小胶质细胞病的代表,小胶质细胞在其发病机制中起关键和原发作用。
- CSF1R突变选择性导致白质变性的潜在机制尚待阐明。
研究设计与样本
- 综述:自2012年发现遗传性弥漫性白质脑病伴轴突球样变的家系中CSF1R基因突变以来,全球已鉴定出70余种不同突变。
- 通过分析突变携带者,对CSF1R相关脑白质病进行了临床、影像和病理学特征描述。
主要发现
- 患者通常在40-50岁出现额颞叶痴呆样表型,伴锥体束和锥体外系体征等运动症状。
- 女性较男性更早出现临床症状。
- 脑影像除白质异常外,胼胝体变薄、白质弥散受限病灶和脑钙化为标志性特征。
- 病理提示原发性轴索病继发脱髓鞘。
- 一例移码突变患者显示集落刺激因子-1受体(CSF1R)单倍剂量不足,促进了Csf1r单倍剂量不足小鼠模型的建立;该小鼠出现与人类CSF1R突变患者一致的临床、影像和病理表型。
局限性
- CSF1R突变选择性导致白质变性的潜在机制尚待阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since the discovery of CSF1R gene mutations in families with hereditary diffuse leukoencephalopathy with spheroids in 2012, more than 70 different mutations have been identified around the world. Through the analyses of mutation carriers, CSF1R-related leukoencephalopathy has been distinctly characterized clinically, radiologically, and pathologically. Typically, patients present with frontotemporal dementia-like phenotype in their 40s-50s, accompanied by motor symptoms, including pyramidal and extrapyramidal signs. Women tend to develop the clinical symptoms at a younger age than men. On brain imaging, in addition to white matter abnormalities, thinning of the corpus callosum, diffusion-restricted lesions in the white matter, and brain calcifications are hallmarks. Primary axonopathy followed by demyelination was suggested by pathology. Haploinsufficiency of colony-stimulating factor-1 receptor (CSF1R) is evident in a patient with a frameshift mutation, facilitating the establishment of Csf1r haploinsufficient mouse model. These mice develop clinical, radiologic, and pathologic phenotypes consistent with those of human patients with CSF1R mutations. In vitro, perturbation of CSF1R signaling is shown in cultured cells expressing mutant CSF1R. However, the underlying mechanisms by which CSF1R mutations selectively lead to white matter degeneration remains to be elucidated. Given that CSF1R mainly expresses in microglia, CSF1R-related leukoencephalopathy is representative of primary microgliopathies, of which microglia have a pivotal and primary role in pathogenesis. In this review, we address the current knowledge of CSF1R-related leukoencephalopathy and discuss the putative pathophysiology, with a focus on microglia, as well as future research directions.
引用
- Konno T, Kasanuki K, Ikeuchi T, et al. CSF1R-related leukoencephalopathy: A major player in primary microgliopathies. Neurology. 2018. PMID: 30429277. doi:10.1212/WNL.0000000000006642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。